Industry Praises PMA-Acceptance Draft Guidance, But Offers A Few Suggestions

Companies are generally happy with FDA’s July 31 draft guidance describing a 15-day "acceptance review" that FDA staff will perform to quickly check that a PMA submission meets minimum requirements.

More from Regulation

More from Policy & Regulation